Feed NATCOPHARM.NS
NA
Natco Pharma Limited
NATCOPHARM.NS · NSE
₹914.30 +0.80% (+₹7.30)
1M -7.09%
Market Cap ₹162.8B
P/E Ratio 11.48x
Div. Yield -
ROE 17.96%
Bulios Fair Price
₹1,363
49.1% upside
Preț actual
₹914.3
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NATCOPHARM.NS sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
87 /100
Cheap P/E 11.48x
EV/EBITDA 9.69x
P/FCF 11.82x
Growth
93 /100
Growing Rev. growth 14.62%
FCF growth 28.87%
Book val. growth 23.68%
Profitability
100 /100
Strong Gross margin 83.07%
Net margin 34.78%
FCF margin 33.77%
Quality
69 /100
Excellent ROIC 11.32%
ROE 17.96%
Asset turnover 0.37x
Debt
100 /100
Low Debt/Equity 0.08x
Current ratio 3.01x
Net debt/EBITDA 0.30x
Stability
25 /100
Unstable Beta 0.18x
Rev. volatility 28.36%
Profitable years 6
Întreabă StockBot despre NATCOPHARM.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Rajeev Nannapaneni
Employees
5,051
Headquarters
Hyderabad
Evenimente viitoare
14 AUG.
Earnings
Upcoming earnings report